- Home
- GORO vs SLGL Comparison
GORO vs SLGL Comparison
Compare GORO & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GORO | SLGL |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.3M | 117.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | GORO | SLGL |
|---|---|---|
| Price | $0.85 | $42.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $1.38 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.4M | 15.1K |
| Earning Date | 11-04-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,430,000.00 | $18,970,000.00 |
| Revenue This Year | $8.76 | $121.82 |
| Revenue Next Year | $85.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 62.04 |
| 52 Week Low | $0.17 | $4.02 |
| 52 Week High | $1.18 | $52.26 |
Technical Indicators
Market Signals| Indicator | GORO | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 59.45 | 57.15 |
| Support Level | $0.82 | $39.26 |
| Resistance Level | $0.89 | $44.04 |
| Average True Range (ATR) | 0.06 | 3.07 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 81.51 | 72.65 |
Price Performance
Historical ComparisonAbout GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.